Violette Shelia M., Chief Scientific Officer at Q32 Bio Inc. ($QTTB), made two open market sales totaling about $18 thousand over the past year. Her most recent sale occurred on February 25, 2026. These transactions rank her 11,084th among nearly 12 thousand insiders for sales volume, well below the average of $8.6 million across about six sales per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | A | Common Stock | 37500 | $0.00 | 129,346.0000 | 12,304,352 | 40.83% | 0.30% |
| Feb. 25, 2026 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | S | Common Stock | 2815 | $4.51 | 91,846.0000 | 12,304,352 | 2.97% | 0.02% |
| Aug. 26, 2025 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | S | Common Stock | 2990 | $1.80 | 94,661.0000 | 12,197,615 | 3.06% | 0.02% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | D | Stock Option (Right to Buy) | 13305 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 13305 | $0.00 | 13,305.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | D | Stock Option (Right to Buy) | 17506 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 17506 | $0.00 | 17,506.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | D | Stock Option (Right to Buy) | 56413 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 56413 | $0.00 | 56,413.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | A | Common Stock | 37500 | $0.00 | 97,651.0000 | 0 | 62.34% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | D | Stock Option (Right to Buy) | 32891 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 32891 | $0.00 | 32,891.0000 | 0 | 9999.99% | 0.00% |
| Oct. 11, 2024 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4361 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 6000 | $0.00 | 32,891.0000 | 0 | 15.43% | 0.00% |
| Oct. 11, 2024 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 213 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | M | Common Stock | 6000 | $7.29 | 60,151.0000 | 0 | 11.08% | 0.00% |
| Oct. 11, 2024 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | M | Common Stock | 4574 | $3.12 | 54,151.0000 | 0 | 9.23% | 0.00% |
| Oct. 8, 2024 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | M | Common Stock | 13300 | $3.12 | 49,577.0000 | 0 | 36.66% | 0.00% |
| Oct. 8, 2024 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 13300 | $0.00 | 213.0000 | 0 | 98.42% | 0.00% |
| March 25, 2024 | Q32 Bio Inc. | $QTTB | Violette Shelia M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 56413 | $0.00 | 56,413.0000 | 0 | 9999.99% | 0.00% |